PANGAEA: Post-authorization Noninterventional German Safety Study of GilEnyA in Relapsing-remitting Multiple Sclerosis (RRMS) patients: A 24-month Interim Analysis of a German Five-Year Fingolimod Registry Study

T.Ziemssen, M. Diaz-Lorente, M. Abdelkader, C. Cornelissen, Germany, Egypt